Tubo-ovarian Abscess
Conditions
Keywords
abscess drainage, abscess size, medical treatment, surgical treatment
Brief summary
Electronic database of our tertiary obstetrics and gynecology clinic was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities.
Detailed description
This retrospective study is conducted at Health Sciences University Turkey, Sisli Hamidiye Etfal Training and Research Hospital Department of Obstetrics and Gynecology. Electronic database was searched for patients who were treated for tub-ovarian abscess during the last 10 years (January 2010- November 2020). Patients' biometric data, admission date and duration, medical and surgical treatment modalities were recorded using an Excel sheet. Patients will be evaluated on the basis of the treatment they receive, length of treatment, if surgically treatment the type of surgery performed. Hospitalization length, readmission, recurrence will be compared between treatment modalities. A change in management strategy over the years if any will be reported.
Interventions
OTHERtuboovarian abscess
Evaluating the surgical and medical management of tuboovarian abscess
Sponsors
Sisli Hamidiye Etfal Training and Research Hospital
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Inclusion criteria
* presence of a pelvic mass \> 3 cm with transvaginal ultrasound or magnetic resonance imaging indication abscess * cervical and uterine tenderness * abdominal rebound-defense under physical examination indication peritoneal irritation * presence of symptoms such as fever, pelvic pain and increase in laboratory infection parameters
Exclusion criteria
* Patients with known malignities * Patients with incomplete data in the clinic's electronic database * Patients who continued their treatment at other centers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Evaluating the management of tuboovarian abscess on the basis of surgical or medical modalities by assessing hospitalization duration and recurrence | 10 years | Patients' demographics data (age, gravity, parity, presence of additional comorbidities and BMI) will be recorded. Their laboratory assessment of infection prior to treatment begin such as CRP an procalcitonin will be recorded. Their treatment modalities in terms of surgery or antibiothepry, duration of hospitalization and recurrence will be recorded. Statistical analysis will be done using SPSS. Student's t test will be used for comparison where necessary. Significance will be evaluated using p-value. |
Countries
Turkey (Türkiye)
Outcome results
None listed